Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,506,163
+$2,860,580 QoQ
Shares Held
490,018
-8.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Sep 30, 2025CallValue
$6,181,056
CallShares
175,200
PutValue
$4,342,968
PutShares
123,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. RPRX ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in RPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,506,163 | 490,018 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,645,583 | 534,306 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,181,056 | 175,200 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $4,342,968 | 123,100 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $4,651,473 | 129,100 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $6,824,082 | 189,400 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $5,896,022 | 189,400 | Call | Defined | 2025-07-21 | |
| 2025-03-31 | $4,018,883 | 129,100 | Put | Defined | 2025-07-21 | |
| 2024-12-31 | $6,352,066 | 249,003 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,898,447 | 526,633 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $15,828,844 | 521,200 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $32,831,592 | 1,168,800 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,763,348 | 728,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $16,298,348 | 530,200 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,295,364 | 618,800 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $73,747,384 | 1,892,900 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,393,585 | 336,100 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,135,874 | 59,100 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||